This Barclays Americas Small Cap Research Summary provides equity research updates on National Energy Services Reunited Corp and Sutro Biopharma.
Key Takeaways
- 1.National Energy Services Reunited Corp (NESR) is expanding its operations in the Jafurah field with a fifth fleet being added.
- 2.Sutro Biopharma's recent clinical trial news regarding STRO-006 is viewed as not impacting the long-term investment thesis.
Table of Contents
- Company Research
- National Energy Services Reunited Corp: Jafurah Continues to Ramp, Waiting for Recovery to Begin
- Replay: Corporate Access: Barclays: EagleRock Land (EROK) Webinar
- Sutro Biopharma: Sigvotatug Vedotin Trial Miss Not Impactful to Our STRO Thesis
- Analyst(s) Certification(s)
- Important Disclosures
- Availability of Disclosures
- Risk Disclosure(s)
- Guide to the Barclays Fundamental Equity Research Rating System
Document Preview
Access the Full Report
Get unlimited access to institutional research reports with a 14-day free trial.
Authors
J. David AndersonEddie KimTheresa ChenLukas ShumwayEtzer Darout
Securities
NESRSTRO
Themes
Small Cap Growth
Regions
North AmericaUnited States
